On July 30, 2025, Moderna announced that the European Commission (EC) granted marketing authorization for the updated formulation of Moderna’s COVID-19 vaccine Spikevax®. The updated vaccine targets the LP.8.1 variant of...more
In Washington: On Friday, President Biden signed an executive order expanding the scope of nutrition assistance programs, an effort to address a growing hunger crisis caused by the COVID-19 pandemic, and heightening worker...more
In Washington: Welcome back and to the new 117th Congress. The House of Representatives met Sunday to swear in new members of Congress and elect Nancy Pelosi (D-CA) to be the Speaker of the House for the fourth time...more
The biopharmaceutical industry is at the forefront of COVID-19 news due to major advances in vaccine development. Now, more than a year since the first case of COVID-19 and nearing a year since daily life has been upended by...more
In Washington: On Monday, Moderna announced that its coronavirus is 94.5% effective against COVID-19 in its phase three testing. The results make Moderna the second company to report preliminary data on a successful...more
In Washington - On Friday, the CDC reversed its guidance advising that it was unnecessary to test people without symptoms of COVID-19. The change came after it was revealed that CDC scientists did not write it. The...more
In Washington: Senate Majority Leader Mitch McConnell (R-KY) on Monday told reporters that when the Senate returns next week Republicans will start discussions on the next coronavirus stimulus package with their Democratic...more
Optimism over promising results for a coronavirus vaccine from Moderna helped drive stocks up on Monday after a rough go of it last week....more